| Announce Date | 08/14/2025 |
| EPS Normalized Actual | $-0.32 (Miss by $-0.25) |
| EPS GAAP Actual | $-0.32 (Miss by $-0.25) |
| Revenue Actual | $0.00212397B |
| Revenue Surprise | Beat by $2.12397M |
| Announce Date | 12/30/2025 (Pre-Market) |
| EPS Normalized Estimate | $0 |
| EPS GAAP Estimate | $0 |
| Revenue Estimate | $0.005B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 0 | INF | 0 | 0 | 0 |
| Dec 2028 | -0.05 | -241.1 | -0.05390793 | -0.0477957 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -0.32 | -0.32 | 0.00212397B | 33.56% | 0.12M |
| FQ1 2025 (Mar 2025) | -0.21 | -0.21 | 2.0423B | 100% | 2040.3M |
| FQ4 2024 (Dec 2024) | -3.5 | -3.5 | 0.00200402B | 100% | -0.5M |
| FQ3 2024 (Sep 2024) | -299.98 | -299.98 | 1.53126B | 100% | 1531.26M |
| FQ2 2024 (Jun 2024) | -0.15 | -0.15 | 0.00141112B | 100% | 0.89M |
| FQ3 2021 (Sep 2021) | -0.0005 | -0.0005 | 9.0E-7B | 100% | 0M |
| FQ4 2021 (Dec 2021) | -0.0219 | -0.0219 | 1.0E-9B | 100% | 0M |
| FQ1 2022 (Mar 2022) | -0.0181 | -0.0181 | 0B | NAN% | 0M |
FQ4 Announce Date
12/30/2025 (Pre-Market)
Consensus EPS Estimates
0
Consensus Revenue Estimates
0.005B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0 | -- | 0 | 0 | 0 |
| FQ3 2026 (Sep 2026) | 0 | -- | 0 | 0 | 0 |
| FQ2 2026 (Jun 2026) | 0 | INF | 0 | 0 | 0 |
| FQ1 2026 (Mar 2026) | 0 | INF | 0 | 0 | 0 |
| FQ4 2025 (Dec 2025) | 0 | INF | 0 | 0 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.01B | -- | 0.01B | 0.01B | 1 |
| FQ3 2026 (Sep 2026) | 0.01B | -- | 0.01B | 0.01B | 1 |
| FQ2 2026 (Jun 2026) | 0B | 46.9 | 0B | 0B | 1 |
| FQ1 2026 (Mar 2026) | 0B | -50957.5 | 0B | 0B | 1 |
| FQ4 2025 (Dec 2025) | 0.01B | 59.92 | 0.01B | 0.01B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
1
Revenue # of in-lines
1
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0 | -0.32 | -0.32 | 100% |
| FQ1 2025 (Mar 2025) | 0 | -0.21 | -0.21 | 100% |
| FQ4 2024 (Dec 2024) | 0 | -3.5 | -3.5 | 100% |
| FQ3 2024 (Sep 2024) | -299.98 | -299.98 | 100% | |
| FQ2 2024 (Jun 2024) | 0 | -0.15 | -0.15 | 100% |
| FQ3 2021 (Sep 2021) | -0.0005 | -0.0005 | 100% | |
| FQ4 2021 (Dec 2021) | -0.0219 | -0.0219 | 100% | |
| FQ1 2022 (Mar 2022) | -0.0181 | -0.0181 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0B | $0B | $0.12M | 5.84% |
| FQ1 2025 (Mar 2025) | $0B | $2.04B | $2040.3M | 99.9% |
| FQ4 2024 (Dec 2024) | $0B | $0B | $-0.5M | -24.75% |
| FQ3 2024 (Sep 2024) | $0B | $1.53B | $1531.26M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0B | $0.89M | 63.12% |
| FQ3 2021 (Sep 2021) | $0B | $0B | $0M | 100% |
| FQ4 2021 (Dec 2021) | $0B | $0B | $0M | 100% |
| FQ1 2022 (Mar 2022) | $0B | $0B | $0M | NAN% |